The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Gilead Sciences to Present at Two Upcoming Investor Conferences

<p class='bwalignc'> <i><b>- 2012 Citi Global Healthcare Conference on February 27</b></i><sup><i><b>th</b></i></sup><i><b> -</b></i><br/><i><b>- 2012 RBC Capital Markets' Healthcare Conference on February 28</b></i><sup><i><b>th</b></i></sup><i><b> -</b></i><br/><i><b>- Webcasts Available Through Gilead Corporate Website -</b></i> </p> <p class='bwalignc'> </p>

Friday, February 24, 2012

Gilead Sciences to Present at Two Upcoming Investor Conferences16:30 EST Friday, February 24, 2012 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the Citi Global Healthcare Conference and the RBC Capital Markets' Healthcare Conference, both taking place in New York. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, and Kevin Young CBE, Gilead's Executive Vice President, Commercial Operations, will provide an overview of the company at the Citi conference on Monday, February 27 at 8:30 a.m. Eastern Standard Time (EST) and the RBC conference on Tuesday, February 28 at 10:30 a.m. EST. To access the live webcasts or replays via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Patrick O?Brien, 650-522-1936Investor Relations